CCA patients showed a higher level of Pyruvate dehydrogenase kinase 1 (PDK1) (58), which has been known to control the metabolic shift during hypoxia via regulating the acetyl-coA production to yield energy in the TCA cycle by mitochondria oxidation (59, 60). This evidence concerns the gene PDK1 and cholangiocarcinoma.